| 6.5991 -1.671 (-20.2%) | 11-13 15:56 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.16 | 1-year : | 7.42 |
| Resists | First : | 5.27 | Second : | 6.36 |
| Pivot price | 4.23 |
|||
| Supports | First : | 3.51 | Second : | 2.92 |
| MAs | MA(5) : | 3.88 |
MA(20) : | 4.52 |
| MA(100) : | 9.97 |
MA(250) : | 15.39 |
|
| MACD | MACD : | -0.5  |
Signal : | -0.6 |
| %K %D | K(14,3) : | 26.9 |
D(3) : | 14.8 |
| RSI | RSI(14): 40.2 |
|||
| 52-week | High : | 96 | Low : | 3.5 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SQL ] has closed above bottom band by 34.5%. Bollinger Bands are 75% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 27 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5 - 5.02 | 5.02 - 5.05 |
| Low: | 3.95 - 3.97 | 3.97 - 3.99 |
| Close: | 3.96 - 4 | 4 - 4.04 |
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.
Tue, 16 Apr 2024
SeqLL (NASDAQ:SQL) Shares Down 20.2% - Defense World
Mon, 18 Sep 2023
Why Rubicon Technologies Shares Are Trading Lower By Over 7%; Here Are 20 Stocks Moving Premarket - AgriF - Benzinga
Fri, 01 Sep 2023
Top 5 Stock Market Gainers: ADTX, BDRX, SQL, MNTS, UPLD - CoinChapter
Tue, 25 Apr 2023
Why Aaron's Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket - Aarons (NYSE:A - Benzinga
Tue, 07 Feb 2023
7 Penny Stocks To Watch With Big News In February; Time To Buy? - Penny Stocks
Thu, 22 Dec 2022
SEQLL INC. GRANTED SECOND 180-DAY EXTENSION BY NASDAQ - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 41 (K) |
| Shares Short P.Month | 25 (K) |
| EPS | -16.4 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.39 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -40 % |
| Return on Equity (ttm) | -113.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0.2 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -13.77 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -0.25 |
| PEG Ratio | 0 |
| Price to Book value | 0.47 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.34 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|